Elagolix Treatment Guidelines for Endometriosis-Associated Pain

Efficacy and Safety Considerations

• The American College of Obstetricians and Gynecologists recommends add-back therapy to reduce bone mineral loss without compromising pain relief efficacy when using elagolix long-term, particularly the 200 mg twice daily dose 1, 2
• Elagolix does not eradicate endometriosis lesions, it only provides symptomatic pain relief through hormonal suppression, a limitation shared with other GnRH-targeting therapies 3

Dosing and Treatment Duration

• No cited facts are available for this section

Quality of Life Improvements

• No cited facts are available for this section

Important Clinical Pitfalls

• No cited facts are available for this section